Comments
Loading...
Global Medical REIT Analyst Ratings and Price Targets | NYSE:GMRE | Benzinga
Global Medical REIT Inc has a consensus price target of $10.69 based on the ratings of 6 analysts. The high is $12 issued by Alliance Global Partners on September 19, 2024. The low is $9 issued by BMO Capital on October 6, 2022. The 3 most-recent analyst ratings were released by Berenberg, Alliance Global Partners, and B. Riley Securities on October 18, 2024, September 19, 2024, and May 13, 2024, respectively. With an average price target of $11.25 between Berenberg, Alliance Global Partners, and B. Riley Securities, there's an implied 43.68% upside for Global Medical REIT Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Berenberg
Alliance Global Partners
B. Riley Securities
BMO Capital
1calculated from analyst ratings
Analyst Ratings for Global Medical REIT
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/12/2025 | Buy Now | — | Citizens Capital Markets | Aaron Hecht57% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 10/18/2024 | Buy Now | 50.06% | Berenberg | Kai Klose13% | → $11.75 | Initiates | → Buy | Get Alert |
| 09/19/2024 | Buy Now | 53.26% | Alliance Global Partners | — | → $12 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | 27.71% | B. Riley Securities | Bryan Maher36% | $11 → $10 | Maintains | Buy | Get Alert |
| 05/08/2023 | Buy Now | 40.49% | B. Riley Securities | Bryan Maher36% | $12 → $11 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 53.26% | B. Riley Securities | Bryan Maher36% | $14 → $12 | Maintains | Buy | Get Alert |
| 10/10/2022 | Buy Now | — | Baird | Amanda Sweitzer17% | — | Downgrade | Outperform → Neutral | Get Alert |
| 10/06/2022 | Buy Now | 14.94% | BMO Capital | John Kim55% | $13 → $9 | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Global Medical REIT (GMRE) stock?
The latest price target for Global Medical REIT (NYSE:GMRE) was reported by Citizens Capital Markets on March 12, 2025. The analyst firm set a price target for $0.00 expecting GMRE to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Global Medical REIT (GMRE)?
The latest analyst rating for Global Medical REIT (NYSE:GMRE) was provided by Citizens Capital Markets, and Global Medical REIT reiterated their market perform rating.
When was the last upgrade for Global Medical REIT (GMRE)?
There is no last upgrade for Global Medical REIT
When was the last downgrade for Global Medical REIT (GMRE)?
The last downgrade for Global Medical REIT Inc happened on October 10, 2022 when Baird changed their price target from N/A to N/A for Global Medical REIT Inc.
When is the next analyst rating going to be posted or updated for Global Medical REIT (GMRE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.
Is the Analyst Rating Global Medical REIT (GMRE) correct?
While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a reiterated with a price target of $0.00 to $0.00. The current price Global Medical REIT (GMRE) is trading at is $7.83, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
